FDA Inspection 1040706 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on January 11, 2018 in Danville, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 11, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Danville, VA (United States)